Back
BioXcel Therapeutics Stock Price Chart
Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
13
BTAI
BioXcel Therapeutics
Last Price:
$1.36
Seasonality Move:
-21.42%
7 Day Trial
ALL ACCESS PASS
$
7
This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing slight selling pressure.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.45 | Sell |
| 20-day SMA: | 1.64 | Sell |
| 50-day SMA: | 1.86 | Sell |
| 200-day SMA: | 6.26 | Sell |
| 8-day EMA: | 1.47 | Sell |
| 20-day EMA: | 1.59 | Sell |
| 50-day EMA: | 2.05 | Sell |
| 200-day EMA: | 11.63 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 36.46 | Sell |
| Chaikin Money Flow: | -15952 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.48 - 1.84) | Sell |
| Bollinger Bands (100): | (1.31 - 4.95) | Sell |
BioXcel Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.42 while BTAI 8-day simple moving average is 1.45, which is a Sell signal.
-
The stock price of BTAI is 1.42 while BioXcel Therapeutics 20-day SMA is 1.64, which makes it a Sell.
-
BioXcel Therapeutics 50-day simple moving average is 1.86 while BTAI share price is 1.42, making it a Sell technically.
-
BTAI stock price is 1.42 and BioXcel Therapeutics 200-day simple moving average is 6.26, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
13
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a SellThe current BioXcel Therapeutics [BTAI] share price is $1.42. The Score for BTAI is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
8.6M
Price in USD:
1.42
Share Volume:
79.8K
BioXcel Therapeutics 52-Week Range
52-Week High:
33.62
52-Week Low:
1.29
Sell
13
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?The BioXcel Therapeutics stock price is 1.42 USD today.
-
Will BTAI stock go up or go down?BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is BioXcel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.42 while BTAI 8-day exponential moving average is 1.47, which is a Sell signal.
-
The stock price of BTAI is 1.42 while BioXcel Therapeutics 20-day EMA is 1.59, which makes it a Sell.
-
BioXcel Therapeutics 50-day exponential moving average is 2.05 while BTAI share price is 1.42, making it a Sell technically.
-
BTAI stock price is 1.42 and BioXcel Therapeutics 200-day simple moving average is 11.63, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $5.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.16 per share, and a decrease next year of $0.77 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
-
BTAI Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting BioXcel Therapeutics is a Sell
-
BioXcel Therapeutics Relative Strength Index (RSI) is 36.46, which suggest BioXcel Therapeutics is oversold
-
The Bollinger Bands (25) for BioXcel Therapeutics is (1.48 - 1.84), which suggest BioXcel Therapeutics is a Sell
-
The Bollinger Bands (100) for BioXcel Therapeutics is (1.31 - 4.95), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.